Molecule Details
| InChIKey | JHMVRJULHPLSFV-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-tert-butyl-2-N-(pyridin-3-ylmethyl)piperazine-1,2-dicarboxamide |
| Canonical SMILES | CC(C)(C)NC(=O)N1CCN(C2c3ccc(Cl)cc3CCc3cc(Br)cnc32)CC1C(=O)NCc1cccnc1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.68 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile